Tanabe Pharma Clinical Trial Information Site

List of Summaries of Clinical Trial Information

The clinical trial information and results posted on ClinicalTrials.gov or CTIS of public registries are available after performing a search in the following.

The studies listed in the “Summary Results” and “Summary Results in Plain Language “ in the “List of Summaries of Clinical Trial Information” are clinical trials in patients that form part of the submission package for products and indications approved in all regions of the US, Europe and Japan where approval is sought, in and after January 2018.
However, the results will not be disclosed if Tanabe Pharma determines that there is a risk that the clinical trial participants could be identified. The results may not be disclosed in the following conditions:

  • ・A third party, such as a company involved in joint development, has not agreed to disclosure.
  • ・Disclosure may interfere with publication in medical journals.
  • ・Disclosure may interfere with the protection of intellectual property rights.

Search

Medical Indication or Disease

Search

Detailed Search

Disease Area
Development Code, Generic Name
Phase
Status of Clinical Trial
Clinical Trial Results
Search  Results: {{resultCount}} case(s)

Search Results

Back to Search
Disease
Area		 Development
Code
(Generic Name)		 Clinical Trial No. Medical Indication
or
Disease		 Phase Status of
Clinical Trial		 ID

ClinicalTrials.gov
CTIS

 Summary of
Clinical Trial		 Summary
Results		 Summary Results in Plain Language
Back to Search
Back to the Top Page

Contact Information

For questions regarding disclosure of clinical trial information, please click here.

https://www.tanabe-pharma.com/en/inquiry/index.html